Wound management is an important and developing global issue. Impaired wound healing is among the most prevalent diabetes consequences, and it is known to be caused by a number of complex causes. For example, neuropathy, hyperglycaemia, and impaired angiogenesis all contribute to a delay in the healing process after a lesion. Generally, moist wound healing creates a suitable environment for wounds and speeds up healing by controlling wound exudate. As a result, materials for wound dressings that promote moist healing have been designed. The most frequently used dressings nowadays include hydrocolloids.
Hydrocolloid is a wafer-shaped bandage that combines gel-forming ingredients and an adhesive substance fused to a flexible, water-repellent outer layer. Alginate is included in some hydrocolloid dressing formulations to improve absorption. This self-adhesive wafer provides a moist healing environment as well as insulation while utilising the body's water and enzyme to keep the wound bed hydrated for optimum wound healing. The hydrocolloid dressings can be applied to a variety of wound types, and they work best on those with poor to moderate drainage. The global hydrocolloid dressing market is expanding at a rapid pace due to the rising number of diabetic patients, the swiftly growing aging population, and the surge in research and development activities.
Newest Insights in the Hydrocolloid Dressing Market
The increasing occurrence of chronic wounds, such as pressure ulcers and diabetic foot ulcers, among the general population is expected to rise the number of patients needing treatment, thus boosting the use of hydrocolloid dressings. As per a report by Research Dive, the global hydrocolloid dressing market is expected to surpass a revenue of $4,725.9 million in the 2022-2031 timeframe. The North America hydrocolloid dressing market is expected to perceive foremost and dominant growth in the years to come. This region is expected to maintain its dominance during the forecast period due to a surge in need for hydrocolloid dressings from several end-use industries like Ambulatory surgery centers (ASCs), home care, and hospitals.
How are Market Players Responding to the Rising Demand for Hydrocolloid Dressing?
Market players are greatly investing in pioneering research and inventions to cater for the rising demand for advanced hydrocolloid dressing. Some of the foremost players in the hydrocolloid dressing market are 3M, Cardinal Health, Smith Nephew, Convatec Inc, Coloplast Corp, Cardinal Health, INTEGRA, Molnlycke, Inc., Medtronic, Abbott, Ltd., and others. These players are focused on planning and devising tactics such as mergers and acquisitions, collaborations, novel advances, and partnerships to reach a remarkable position in the global market.
In August 2018, CP Kelco, a nature-based ingredient solutions company, revealed that hydrocolloids can offer solutions for sugar reduction, ambient drinking yoghurts, and more.
- In January 2019, GEMCO Medical, a leading provider of medical products, announced the expansion of the GEMCORE360? brand of advanced wound care products. The GEMCORE360? Advanced Wound Care collection offers dressings to support the healing of all serious and chronic wounds. It includes hydrocolloid dressings, alginate dressings, transparent thin films, foam dressings, silver alginate dressings, and PHMB foam dressings.
- In September 2022, Bioré, a small face-care company, introduced Cover & Conquer matte acne patches as an addition to the renowned pore strip with acne treatment. These acne patches are made using hydrocolloids to eliminate newly evolving or prevailing pimples.
COVID-19 Impact on the Global Hydrocolloid Dressing Market
The unpredicted rise of the coronavirus pandemic in 2020 has adversely impacted the global hydrocolloid dressing market. During the pandemic period, the closure of manufacturing facilities, the global economic recession, and supply chain disruptions, eventually reduced the global market size. Throughout the pandemic, any activity or service that was deemed unnecessary was discontinued. Many hospitals formerly classified wound care as non-essential. Patients with hypertension, diabetes, peripheral artery disease, and venous insufficiency are most prone to COVID-19 infection, which has resulted in secondary infections, amputations, sepsis, and even death. Apart from this, COVID-19's impact on logistics led to an increase in producers' expenses for hydrocolloids and raw materials. All these factors significantly hindered the market growth. However, with the relaxation of the pandemic, the global hydrocolloid dressing market is expected to recuperate from incurred losses and grow massively in the upcoming years.